Cargando…

Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours

The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accep...

Descripción completa

Detalles Bibliográficos
Autores principales: Crocetti, Laura, de Baere, Thierry, Lencioni, Riccardo
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816824/
https://www.ncbi.nlm.nih.gov/pubmed/19924474
http://dx.doi.org/10.1007/s00270-009-9736-y
_version_ 1782177139031801856
author Crocetti, Laura
de Baere, Thierry
Lencioni, Riccardo
author_facet Crocetti, Laura
de Baere, Thierry
Lencioni, Riccardo
author_sort Crocetti, Laura
collection PubMed
description The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when liver transplantation or surgical resection are not suitable options [1, 2]. In addition, RFA is considered a viable alternate to surgery (1) for inoperable patients with limited hepatic metastatic disease, especially from colorectal cancer, and (2) for patients deemed ineligible for surgical resection because of extent and location of the disease or concurrent medical conditions [3]. These guidelines were written to be used in quality-improvement programs to assess RFA of HCC and liver metastases. The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates.
format Text
id pubmed-2816824
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28168242010-02-13 Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours Crocetti, Laura de Baere, Thierry Lencioni, Riccardo Cardiovasc Intervent Radiol Cirse Guidelines The development of image-guided percutaneous techniques for local tumour ablation has been one of the major advances in the treatment of liver malignancies. Among these methods, radiofrequency ablation (RFA) is currently established as the primary ablative modality at most institutions. RFA is accepted as the best therapeutic choice for patients with early-stage hepatocellular carcinoma (HCC) when liver transplantation or surgical resection are not suitable options [1, 2]. In addition, RFA is considered a viable alternate to surgery (1) for inoperable patients with limited hepatic metastatic disease, especially from colorectal cancer, and (2) for patients deemed ineligible for surgical resection because of extent and location of the disease or concurrent medical conditions [3]. These guidelines were written to be used in quality-improvement programs to assess RFA of HCC and liver metastases. The most important processes of care are (1) patient selection, (2) performing the procedure, and (3) monitoring the patient. The outcome measures or indicators for these processes are indications, success rates, and complication rates. Springer-Verlag 2009-11-19 2010-02 /pmc/articles/PMC2816824/ /pubmed/19924474 http://dx.doi.org/10.1007/s00270-009-9736-y Text en © Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2009
spellingShingle Cirse Guidelines
Crocetti, Laura
de Baere, Thierry
Lencioni, Riccardo
Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
title Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
title_full Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
title_fullStr Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
title_full_unstemmed Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
title_short Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
title_sort quality improvement guidelines for radiofrequency ablation of liver tumours
topic Cirse Guidelines
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816824/
https://www.ncbi.nlm.nih.gov/pubmed/19924474
http://dx.doi.org/10.1007/s00270-009-9736-y
work_keys_str_mv AT crocettilaura qualityimprovementguidelinesforradiofrequencyablationoflivertumours
AT debaerethierry qualityimprovementguidelinesforradiofrequencyablationoflivertumours
AT lencioniriccardo qualityimprovementguidelinesforradiofrequencyablationoflivertumours